Article
Effects of R-enantiomer (GR66234A) and L-enantiomer (GR66235A) of telupidine, a new dihydropyridine derivative, on cell lines displaying the multidrug resistant phenotype.
Haematologica - 1 Jan 2000
Tolomeo M, Gancitano R A, Musso M, Porretto F, Perricone R, Abbadessa V, Cajozzo A
Abstract excerpt
BACKGROUND: Many dihydropyridine analogues with calcium channel blocker activity are able to reverse multidrug resistance (MDR). We studied the daunorubicin resistance reversing activity of the R enantiomer (GR66234A) and the L-enantiomer (GR66235 A) of teludipine, a new lipophilic calcium channel blocker synthesized by Glaxo. METHODS: The daunorubicin resistance reversing activity of the enantiomers of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.